Hydralazine 100mg Injection Vials from Japan
Sterile injectable vials containing 100mg hydralazine for IV use in severe hypertension crises. Meets HTS 3004.90.92.20 as unmixed cardiovascular product in measured doses, suitable for hospital retail dispensing.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide USP <71> sterility and <85> bacterial endotoxin certificates
• Maintain cold chain (2-8°C) with validated shipping; declare as pharmaceutical